UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000046759 |
|---|---|
| Receipt number | R000053345 |
| Scientific Title | Development of a patient prognosis prediction model using prehospital information and emergency room data |
| Date of disclosure of the study information | 2022/01/28 |
| Last modified on | 2023/07/31 09:13:26 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Development of a patient prognosis prediction model using prehospital information and emergency room data
Acronym
Development of a patient prognosis prediction model using prehospital information and emergency room data
Scientific Title
Development of a patient prognosis prediction model using prehospital information and emergency room data
Scientific Title:Acronym
Development of a patient prognosis prediction model using prehospital information and emergency room data
Region
| Japan |
Condition
Condition
All patients transported to the emergency room at the Collaborative Research Facility
Classification by specialty
| Emergency medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
In addition to investigating the actual conditions of patients who receive emergency care, we will examine the degree to which the severity assessment at the time of emergency care is consistent with the actual severity, and the degree to which there are discrepancies.
Basic objectives2
Others
Basic objectives -Others
To develop an appropriate risk classification and prognostic model for emergency patients based on prehospital information.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Agreement between the severity reported by the emergency services and the actual severity
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 1 | years-old | <= |
Age-upper limit
| 100 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
All patients who were transported to the emergency room of the collaborating institutions from the date when each institution introduced NSER to March 2024 will be included.
Key exclusion criteria
Patients who have expressed their refusal to allow their clinical data to be used in research according to the requirements of the opt-out (but not if their personal information has already been removed and they cannot be identified). The opt-out will be available in the emergency room of each collaborating institution, on the institution's webpage, and on TXP Medical's webpage.
Target sample size
50000
Research contact person
Name of lead principal investigator
| 1st name | KEIBUN |
| Middle name | |
| Last name | LIU |
Organization
The Prince Charles Hospital
Division name
Critical Care Research Group
Zip code
4032
Address
627 Rode Rd, Chermside QLD 4032
TEL
080-4790-7701
keiliu0406@gmail.com
Public contact
Name of contact person
| 1st name | KEIBUN |
| Middle name | |
| Last name | LIU |
Organization
The Prince Charles Hospital
Division name
Critical Care Research Group
Zip code
4032
Address
627 Rode Rd, Chermside QLD 4032
TEL
080-4790-7701
Homepage URL
keiliu0406@gmail.com
Sponsor or person
Institute
TXP Medical
Institute
Department
Personal name
Funding Source
Organization
NA
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
TXP Medical Co. Ltd.
Address
252, South Research Building, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan
Tel
03-5615-8433
keibun.liu@txpmedical.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 01 | Month | 28 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
10000
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2022 | Year | 01 | Month | 26 | Day |
Date of IRB
| 2022 | Year | 01 | Month | 26 | Day |
Anticipated trial start date
| 2022 | Year | 01 | Month | 28 | Day |
Last follow-up date
| 2024 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Retrospective study
Management information
Registered date
| 2022 | Year | 01 | Month | 28 | Day |
Last modified on
| 2023 | Year | 07 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053345
